Feb. 12, 2009--Biotec Pharmacon reports that Biothera has been denied permission to file a motion to reconsider the U.S District Court Order of 28 January, 2009, which largely ruled in Biotec Pharmacon's favour in a patent infringement suit. The Court's decision confirms that all of Biothera's claims under 12 of 14 U.S. patents at issue have been dismissed from the case without even requiring a trial.
The details can be read here.
No comments:
Post a Comment